IL253796A0
(en )
2017-09-28
Therapeutically active compounds and their methods of use
IL270347B
(en )
2021-08-31
Therapeutically active compounds and their methods of use
IL251246A0
(en )
2017-05-29
Therapeutically active compounds and their methods of use
ZA201905677B
(en )
2022-12-21
Glycan-interacting compounds and methods of use
ZA201600667B
(en )
2020-12-23
Therapeutically active compounds and their methods of use
HUE068842T2
(en )
2025-01-28
Compounds and their methods of use
IL274504A
(en )
2020-06-30
Acss2 inhibitors and methods of use thereof
IL283387A
(en )
2021-07-29
Diarylhydantoin compounds and methods of use thereof
IL256515A
(en )
2018-02-28
Therapeutic peptides and methods of use thereof
IL265955A
(en )
2019-05-30
Therapeutic compounds and methods of use thereof
IL285928A
(en )
2021-10-31
Fulvestrant formulations and methods of their use
PT3380525T
(en )
2024-02-05
Pharmaceutical formulations and methods of use thereof
IL255565A
(en )
2018-01-31
Substituted benzamides and methods of use thereof
GB201715194D0
(en )
2017-11-01
Compounds and their therapeutic use
EP3496804A4
(en )
2020-01-15
Bioelectric devices and methods of use
ZA201906238B
(en )
2020-09-30
New therapeutical use of h3-ligands
GB201617064D0
(en )
2016-11-23
Compounds and their therapeutic use
IL270011B
(en )
2022-03-01
Therapeutic compounds and methods
EP3749691A4
(en )
2021-10-27
Angptl8-binding agents and methods of use thereof
ZA201802134B
(en )
2020-08-26
Therapeutic compounds and methods of use thereof
EP3313427A4
(en )
2018-12-26
Therapeutic peptides and methods of use thereof
IL274433A
(en )
2020-06-30
Fulvestrant formulations and methods of their use
ZA201700571B
(en )
2021-05-26
Therapeutically active compounds and their methods of use
GB201709186D0
(en )
2017-07-26
Construction block and methods of use
HK40034351A
(en )
2021-04-23
Angptl8-binding agents and methods of use thereof